PureCycle Technologies, Inc.

NasdaqCM:PCT Stock Report

Market Cap: US$2.0b

PureCycle Technologies Valuation

Is PCT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PCT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PCT ($11.99) is trading below our estimate of fair value ($72.08)

Significantly Below Fair Value: PCT is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PCT?

Key metric: As PCT is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for PCT. This is calculated by dividing PCT's market cap by their current book value.
What is PCT's PB Ratio?
PB Ratio8.6x
BookUS$241.42m
Market CapUS$2.02b

Price to Book Ratio vs Peers

How does PCT's PB Ratio compare to its peers?

The above table shows the PB ratio for PCT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average2.7x
TROX Tronox Holdings
1x95.1%US$1.8b
KRO Kronos Worldwide
1.5xn/aUS$1.3b
HWKN Hawkins
6x6.1%US$2.6b
OEC Orion
2.1x52.9%US$1.0b
PCT PureCycle Technologies
8.6x60.5%US$2.0b

Price-To-Book vs Peers: PCT is expensive based on its Price-To-Book Ratio (8.6x) compared to the peer average (2.7x).

Price to Book Ratio vs Industry

How does PCT's PB Ratio compare vs other companies in the US Chemicals Industry?

8 CompaniesPrice / BookEstimated GrowthMarket Cap
CGA China Green Agriculture
0.3xn/aUS$27.37m
DNMR Danimer Scientific
0.08x35.2%US$18.51m
GURE Gulf Resources
0.04xn/aUS$6.79m
BON Bon Natural Life
0.2xn/aUS$5.36m
PCT 8.6xIndustry Avg. 1.6xNo. of Companies10PB01.22.43.64.86+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: PCT is expensive based on its Price-To-Book Ratio (8.6x) compared to the US Chemicals industry average (1.6x).

Price to Book Ratio vs Fair Ratio

What is PCT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PCT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio8.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate PCT's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PCT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$11.99
US$13.10
+9.3%
16.1%US$15.00US$9.50n/a5
Nov ’25US$12.87
US$8.80
-31.6%
34.0%US$14.00US$6.00n/a5
Oct ’25US$8.81
US$9.20
+4.4%
40.3%US$16.00US$6.00n/a5
Sep ’25US$6.10
US$9.20
+50.8%
40.3%US$16.00US$6.00n/a5
Aug ’25US$7.45
US$8.38
+12.4%
54.6%US$16.00US$4.00n/a4
Jul ’25US$5.83
US$8.10
+38.9%
51.0%US$16.00US$4.00n/a5
Jun ’25US$5.19
US$7.80
+50.3%
54.0%US$16.00US$4.00n/a5
May ’25US$4.67
US$7.80
+67.0%
54.0%US$16.00US$4.00n/a5
Apr ’25US$5.88
US$7.80
+32.7%
54.0%US$16.00US$4.00n/a5
Mar ’25US$6.07
US$7.00
+15.3%
66.4%US$16.00US$3.00n/a5
Feb ’25US$4.04
US$7.00
+73.3%
66.4%US$16.00US$3.00n/a5
Jan ’25US$4.05
US$7.60
+87.7%
58.0%US$16.00US$3.00n/a5
Dec ’24US$4.63
US$9.90
+113.8%
38.1%US$16.00US$6.00n/a5
Nov ’24US$4.18
US$14.92
+256.9%
14.0%US$18.00US$12.00US$12.876
Oct ’24US$5.61
US$14.92
+165.9%
14.0%US$18.00US$12.00US$8.816
Sep ’24US$9.13
US$14.92
+63.4%
14.0%US$18.00US$12.00US$6.106
Aug ’24US$11.31
US$13.58
+20.1%
11.3%US$16.00US$12.00US$7.456
Jul ’24US$10.69
US$12.92
+20.8%
15.6%US$16.00US$10.00US$5.836
Jun ’24US$7.00
US$12.42
+77.4%
20.1%US$16.00US$9.00US$5.196
May ’24US$6.19
US$12.42
+100.6%
20.1%US$16.00US$9.00US$4.676
Apr ’24US$7.00
US$11.70
+67.1%
17.8%US$15.00US$9.00US$5.885
Mar ’24US$6.17
US$13.40
+117.2%
12.1%US$15.00US$11.00US$6.075
Feb ’24US$8.32
US$13.50
+62.3%
11.1%US$15.00US$11.00US$4.046
Jan ’24US$6.76
US$13.50
+99.7%
11.1%US$15.00US$11.00US$4.056
Dec ’23US$6.18
US$13.50
+118.4%
11.1%US$15.00US$11.00US$4.636
Nov ’23US$8.10
US$16.33
+101.6%
12.1%US$20.00US$14.00US$4.186

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Trinseo

US$117.5m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.25

7D

-10.2%

1Y

-49.9%

Huntsman

US$3.3b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.42

7D

-1.3%

1Y

-22.1%

CMOC Group

HK$166.5b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.77

7D

1.7%

1Y

40.1%